UK-based healthtech startup Apricity has raised €17 million in a Series B round led by Swiss healthtech investor MTIP, with participation from Barcelona-based specialist consumer fund Iris Ventures. Apricity is aiming to become Europe’s leading fertility player with its virtual fertility clinic solution that combines personal, patient-centric fertility care with cutting-edge tech, including AI algorithms and 3D reconstruction technology for embryos. The startup plans to use the new funds to expand geographically, accelerate growth in the UK, and further develop its technology.
Apricity has raised €17 million in a Series B round led by MTIP and participated in by Iris Ventures. The startup plans to use the funding to accelerate growth in the UK and expand geographically, with plans to enter Spain before the end of the year, followed by Germany and Italy. The funding will also be used to further develop its technology, including expanding its at-home services to include at-home ultrasound scans in select areas.
Caroline Noublanche, founder and CEO of Apricity, expressed excitement over the funding and the valuable expertise of MTIP and Iris Ventures. Marc Dietrich, who joins the board of directors on behalf of MTIP, believes fertility tech is one of the most important areas of healthcare innovation, and MTIP is excited to support Apricity as it leads the industry to new heights. The virtual clinic provides continuous, personalized support through its app and has seen rapid growth this past year, with revenue and customer growth more than doubling.
Apricity was launched in the UK in 2018 and has since pioneered new technologies to transform fertility care, including first-of-its-kind AI algorithms that identify the most suitable fertility treatment for patients and determine the best embryo for selection through 3D reconstruction. Apricity is also the first company to develop 3D reconstruction technology for embryos to assist in fertility treatments. The startup acquired Madrid-based period-tracking app Woom in May 2022 and has signed up major corporate customers which use Apricity’s services as part of their employee benefits, accounting for more than one-third of its revenue.
Apricity’s mission is to become the leading fertility player in Europe by providing a smoother patient experience through its virtual fertility clinic. The startup plans to expand geographically, develop its technology, and accelerate growth in the UK with the €17 million raised in its Series B round. The funding was led by MTIP and participated in by Iris Ventures, who both expressed excitement over Apricity’s potential and patient-centric approach to fertility care.
